Trials / Completed
CompletedNCT07219017
A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants
Mass Balance Study of [14C] ABBV-1354 (Icalcaprant) in Healthy Male Subjects Following Single Oral Dose Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study is to assess the mass balance of oral ABBV-1354 in healthy adult male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABBV-1354 | Oral solution |
Timeline
- Start date
- 2025-10-15
- Primary completion
- 2025-12-09
- Completion
- 2025-12-09
- First posted
- 2025-10-21
- Last updated
- 2026-01-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07219017. Inclusion in this directory is not an endorsement.